In the span of eight months, Big Pharma companies took over four of the hottest radiopharmaceutical players in the industry.

In a phase 3 trial, Tenpoint Therapeutics’ eye drop—a combination of carbachol and brimonidine—improved vision for patients ...

Mendaera has found a leader with deep medical robotics experience to lead its commercialization push. Eric Davidson has taken ...

Despite weathering significant criticism from lawmakers and patient groups over the steep cost of its rare disease med ...

Havas is forging deeper into the GLP-1 space with a series of YouTube videos about the drug class and its impact on the world ...